$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A01N-063/00
  • A61K-035/26
  • A61K-035/28
  • C12N-005/08
  • C12N-005/00
출원번호 UP-0070543 (2008-02-19)
등록번호 US-7655225 (2010-03-31)
발명자 / 주소
  • Peled, Tony
  • Treves, Avi
  • Rosen, Oren
출원인 / 주소
  • Gamida Cell, Ltd.
대리인 / 주소
    Elrifi, Esq., Ivor R.
인용정보 피인용 횟수 : 0  인용 특허 : 172

초록

Ex vivo and in vivo methods of expanding a population of stem and/or progenitor cells, while at the same time reversibly inhibiting differentiation of the stem and/or progenitor cells by providing the stem and/or progenitor cells with an effective amount of at least one copper chelate, so as to main

대표청구항

What is claimed is: 1. A method of hematopoietic stem and/or progenitor cells transplantation comprising: (a) obtaining the hematopoietic stem and/or progenitor cells to be transplanted from a donor; (b) providing said hematopoietic stem and/or progenitor cells ex-vivo with conditions for cell prol

이 특허에 인용된 특허 (172)

  1. Tkachuk Zenovy (Kiev SUX) Kvasyuk Eugeny (Kiev SUX) Matsuka Gennady (Kiev SUX) Mikhailopulo Igor (Kiev SUX), (2′-5′) oligoadenylate analogues useful as inhibitors of host-v5.-graft response.
  2. Fesus Laszlo,HUX ; Szondy Zsuzsa,HUX ; Reichert Uwe,FRX, .gamma.-RAR antagonist ligand or .alpha.-RAR agonist ligand as an apoptosis inhibitor.
  3. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), 2′,5′-phosphorothioate oligoadenylates and their covalent conjugates with polylysine.
  4. Jarrett Robert D. (Painesville OH) McCain G. Howard (Painesville OH), Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors.
  5. Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR) Stirchak Eugene P. (Corvallis OR), Alpha-morpholino ribonucleoside derivatives and polymers thereof.
  6. Dubensky ; Jr. Thomas W. ; Polo John M. ; Ibanez Carlos E. ; Chang Stephen M. W. ; Jolly Douglas J. ; Driver David A., Alphavirus structural protein expression cassettes.
  7. Dubensky ; Jr. Thomas W. ; Polo John M. ; Ibanez Carlos E. ; Chang Stephen M. W. ; Jolly Douglas J. ; Driver David A. ; Belli Barbara A., Alphavirus vector constructs.
  8. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphorothioamidate oligonucleotide deratives.
  9. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphotriester oligonucleotide derivatives.
  10. Philip E. Thorpe ; Rolf A. Brekken, Antibody compositions for selectively inhibiting VEGF.
  11. Philip E. Thorpe ; Rolf A. Brekken, Antibody conjugate compositions for selectively inhibiting VEGF.
  12. Rubenstein Kenneth Edward (Palo Alto CA) Leute Richard K. (Sunnyvale CA), Antibody steric hindrance immunoassay with two antibodies.
  13. Zhang Hong ; Cowsert Lex M., Antisense modulation of caspase 3 expression.
  14. Frossard Philippe M. (Palo Alto CA), Apo AI/CIII genomic polymorphisms predictive of atherosclerosis.
  15. Milbrandt Jeffrey D. ; Baloh Robert H., Artemin, a novel neurotrophic factor.
  16. De Mesmaeker Alain (Kaenerkinden CHX) Lebreton Jacques (Marseilles FRX) Waldner Adrian (Allschwil CHX) Cook Phillip D. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  17. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Morvan Francois (Montpellier FRX), Backbone modified oligonucleotide analogs and solid phase synthesis thereof.
  18. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Vasseur Jean J. (San Marcos CA) Debart Francoise (Montpellier FRX), Backbone modified oligonucleotide analogues.
  19. Sanghvi Yogesh S. (San Marcos CA) Cook Phillip D. (Vista CA), Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling.
  20. Matteucci Mark D. (Burlingame CA) Cao Xiaodong (Carlsbad CA), Binding compentent oligomers containing unsaturated 3′,5′and 2′,5′linkages.
  21. Knaack, Christian; Andre, Gerald; Chavarie, Claude, Bioreactor for the perfusion culture of cells.
  22. Halberstadt Craig R. (Ann Arbor MI) Midgley A. Rees (Ann Arbor MI), Bioreactor system.
  23. Cerami Anthony (Shelter Island NY) Bucala Richard J. (New York NY), Blood-borne mesenchymal cells.
  24. Wu George Y. (Bloomfield CT) Wu Catherine H. (Bloomfield CT), Carrier system and method for the introduction of genes into mammalian cells.
  25. Geoffrey D. Block, Cell structure media for mammalian cells.
  26. Capon Daniel J. ; Tian Huan ; Smith Douglas H. ; Winslow Genine A. ; Siekevitz Miriam, Chimeric receptors comprising janus kinase for regulating cellular pro liferation.
  27. Haber Edgar (Weston MA), Composition and method for determining the size and location of myocardial infarcts.
  28. Kmiec Eric B. (Malvern PA), Compounds and methods for site directed mutations in eukaryotic cells.
  29. Ohtsuka Eiko (Sappro JPX) Inoue Hideo (Sappro JPX) Morisawa Hirokazu (Kawasaki JPX) Shibahara Susumu (Kawasaki JPX) Mukai Sachiko (Kawasaki JPX) Nishihara Tohru (Kurashiki JPX), Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and st.
  30. Cook Phillip D. (San Marcos CA) Teng Kelly (San Diego CA), Conjugated 4′-desmethyl nucleoside analog compounds.
  31. Kraus Morey (Worcester MA) Friberg Jill (Worcester MA), Continuous selective clonogenic expansion of relatively undifferentiated cells.
  32. Tsai Schickwann ; Collins Steven J., Creating novel hematopoietic cell lines by expressing altered retinoic acid receptors.
  33. Ni Jian ; Yu Guo-Liang ; Gentz Reiner ; Dillon Patrick J., Cytostatin III.
  34. Ni Jian ; Yu Guo-Liang ; Gentz Reiner ; Dillon Patrick J., Cytostatin III nucleic acids encoding.
  35. Capon Daniel J. ; Tian Huan ; Smith Douglas H. ; Winslow Genine A. ; Siekevitz Miriam, DNA encoding an intracellular chimeric receptor comprising Janus kinase.
  36. Baxter Anthony D. (Northwich GB2) Baylis Eric K. (Stockport GB2) Collingwood Stephen P. (Westhoughton GB2) Taylor Roger J. (Stretford GB2) De Mesmaeker Alain (Kanerkinden CHX) Schmit Chantal (Basel C, Dinucleoside phosphinates and their pharmaceutical compositions.
  37. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Konstanz DEX), Dual action 2′,5′-oligoadenylate antiviral derivatives and uses thereof.
  38. Mullon Claudy Jean Paul ; Gagnon Kerry Ann ; Tosone Christine Marie ; Jauregui Hugo Osyaldo, Dual fiber bioreactor.
  39. Mullon, Claudy Jean Paul; Gagnon, Kerry Ann; Tosone, Christine Marie; Jauregui, Hugo Osvaldo, Dual fiber bioreactor.
  40. Uzgiris Egidijus E. (Schenectady NY), Electrophoretic method of detecting antigen-antibody reaction.
  41. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), Encapsulated 2′,5′-phosphorothioate oligoadenylates.
  42. Joyce Gerald F. ; Breaker Ronald R., Enzymatic DNA molecules.
  43. Dubensky ; Jr. Thomas W. ; Polo John M. ; Jolly Douglas J. ; Driver David A., Eukaryotic layered vector initiation systems.
  44. Dubensky ; Jr. Thomas W. ; Polo John M. ; Jolly Douglas J. ; Driver David A., Eukaryotic layered vector initiation systems.
  45. Thomas W. Dubensky, Jr. ; John M. Polo ; David A. Driver, Eukaryotic layered vector initiation systems for production of recombinant proteins.
  46. Froehler Brian C. (Belmont CA), Exonuclease-resistant oligonucleotides.
  47. Su Wei-Wen W. (47-673 Alawiki St. Kaneohe HI 96744), External-loop perfusion air-lift bioreactor.
  48. Ullman Edwin F. (Atherton CA) Schwarzberg Moshe (Palo Alto CA), Fluorescence quenching with immunological pairs in immunoassays.
  49. Cook Phillip D. (Vista CA) Monia Brett P. (Carlsbad CA), Gapped 2′modified oligonucleotides.
  50. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Heteroatomic oligonucleoside linkages.
  51. Teng Kelly (San Diego CA) Sanghvi Yogesh S. (San Marcos CA) Cook Phillip Dan (San Marcos CA), Heteroatomic oligonucleoside linkages.
  52. Caplan Arnold I. (Cleveland Heights OH) Haynesworth Stephen E. (Cleveland Heights OH), Human mesenchymal stem cells.
  53. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  54. Wands Jack R. (Waban MA) Zurawski ; Jr. Vincent R. (West Chester PA) Schoemaker ; Hubert J. P. (Newton MA), Immunoassay utilizing monoclonal high affinity IgM antibodies.
  55. Weiss Samuel,CAX ; Reynolds Brent,CAX ; Hammang Joseph P. ; Baetge E. Edward, In vitro growth and proliferation of multipotent neural stem cells and their progeny.
  56. Morgan Jeffrey R. (Brighton MA) Mulligan Richard C. (Cambridge MA), In vivo introduction and expression of foreign genetic material in epithelial cells.
  57. Bonjouklian Rosanne (Zionsville IN) Dodge Jeffrey A. (Indianapolis IN) Vlahos Chris J. (Carmel IN), Inhibition of phosphatidylinositol 3-kinase with 17 b 상세보기
  • Bonjouklian Rosanne (Zionsville IN) Vlahos Chris J. (Carmel IN) Powis Garth (Tucson AZ), Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof.
  • Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  • Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  • Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke Shee L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  • Morgan Jeffrey R. (Brighton MA) Mulligan Richard C. (Cambridge MA), Introduction and expression of foreign genetic material in epithelial cells.
  • Simons Malcolm J. (Fryerstown AUX), Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes.
  • Agrawal Sudhir (Shrewsbury MA), Inverted chimeric and hybrid oligonucleotides.
  • Prockop Darwin J. ; Pereira Ruth F. ; Leeper Dennis B. ; O'Hara Michael D., Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects.
  • Bruder Scott P. ; Caplan Arnold I. ; Haynesworth Stephen E., Lineage-directed induction of human mesenchymal stem cell differentiation.
  • Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Linear aminoalkylphosphoramidate oligonucleotide derivatives.
  • Brown Ronald L., Method for culturing CD34.sup.+ cells in a serum-free medium.
  • Kathleen E. Rodgers ; Gere S. DiZerega, Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation.
  • Ronald L. Brown, Method for repopulating human bone marrow comprising culturing CD34+ cells in a serum free medium.
  • Dubensky ; Jr. Thomas W. ; Polo John M. ; Chang Steven M.W. ; Jolly Douglas J., Method for stimulating an immune response utilizing recombinant alphavirus particles.
  • Emerson Stephen G. (Ann Arbor MI) Clarke Michael F. (Ann Arbor MI) Palsson Bernhard O. (Ann Arbor MI), Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultur.
  • Smulson Mark E. (Washington DC) Bhatia Kishor (Arbutus MD) Huppi Konrad (Reston VA), Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for hu.
  • Matthews William ; Austin Timothy W., Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides.
  • Klein Elliott S. ; Nagpal Sunil ; Chandraratna Roshantha A., Method of identifying negative hormone and/or antagonist activities.
  • Capon Daniel J. ; Tian Huan ; Smith Douglas H. ; Winslow Genine A. ; Siekevitz Miriam, Method of inducing a cell to proliferate using a chimeric receptor comprising janus kinase.
  • Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  • Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  • Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  • Orgill Dennis P. ; Butler Charles E. ; Barlow Mark ; Ritterbush Scott ; Yannas Ioannis V. ; Compton Carolyn C., Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft.
  • Rosenthal Gary J. (Boulder CO) Gerber Michael J. (Denver CO), Method of stimulating hematopoiesis with hemoglobin.
  • Emerson Stephen G. ; Clarke Michael F. ; Palsson Bernhard O., Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 sec.
  • Pykett, Mark J.; Rosenzweig, Michael; Kaplan, Richard B., Methods and devices for the long-term culture of hematopoietic progenitor cells.
  • Walder Joseph A. (Iowa City IA) Walder Roxanne Y. (Iowa City IA) Eder Paul S. (Iowa City IA) Dagle John M. (Iowa City IA), Methods for blocking the expression of specifically targeted genes.
  • Thomas Terry,CAX ; Lansdorp Peter,CAX, Methods for preparing enriched human hematopoietic cell preparations.
  • Itskovitz Eldor,Joseph; Gerecht Nir,Sharon, Methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells.
  • Peled, Tony; Fibach, Eitan; Treves, Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  • Peled, Tony; Fibach, Eitan; Treves, Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  • Peled,Tony; Fibach,Eitan; Treves,Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  • Peled,Tony; Treves,Avi; Rosen,Oren, Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby.
  • Klein Elliott S. ; Nagpal Sunil ; Chandraratna Roshantha A., Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities.
  • Patchen Myra L. ; Bleicher Paul, Mobilization of peripheral blood precursor cells by .beta.(1,3)-glucan.
  • Trojanowski John Q. (Philadelphia PA) Lee Virginia M-Y. (Philadelphia PA), Modified avidin-biotin technique.
  • Matteucci Mark (Burlingame CA) Jones Robert J. (Daly City CA) Munger John (San Francisco CA), Modified internucleoside linkages having one nitrogen and two carbon atoms.
  • Beaton Graham (Boulder CO) Fisher Eric F. (Boulder CO), Modified oligonucleotides and intermediates useful in nucleic acid therapeutics.
  • Bellet Dominique (Paris MA FRX) Wands Jack R. (Waban MA), Multiepitopic immunometric assay.
  • Ts\o Paul O. P. (2117 Folkstone Rd. Lutherville MD 21093) Miller Paul S. (225 Hopkins Rd. Baltimore MD 21212), Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof.
  • Walder Joseph A. (Iowa City IA) Walder Roxanne Y. (Iowa City IA), Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled.
  • Ni Jian ; Yu Guo-Liang ; Gentz Reiner L., Nucleic acid molecules encoding cytostatin II.
  • Ingham Philip W.,GBX ; McMahon Andrew P. ; Tabin Clifford J., Nucleic acids encoding hedgehog proteins.
  • Ingham Philip W.,GBX ; McMahon Andrew P. ; Tabin Clifford J. ; Bumcrot David A. ; Marti-Gorostiza Elisa, Nucleic acids encoding hedgehog proteins.
  • Meyer ; Jr. Rich B. (Woodinville WA) Adams A. David (Snohomish WA) Petrie Charles R. (Woodinville WA), Oligo (aa 상세보기
  • Letsinger Robert L. (Wilmette IL) Gryaznov Sergei M. (San Mateo CA), Oligodeoxyribonucleotides including 3′-aminonucleoside-phosphoramidate linkages and terminal 3′-amino groups.
  • Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms.
  • Hecht Sidney M. (Charlottesville VA), Oligonucleotide N-alkylphosphoramidates.
  • Bischofberger Norbert (San Carlos CA) Kent Ken (Mountain View CA) Wagner Rick (Burlingame CA) Buhr Chris (Daly City CA) Lin Kuei-Ying (Fremont CA), Oligonucleotide analogs capable of passive cell membrane permeation.
  • Benner Steven A. (Grossmannstrasse 16 ; #7 CH-8049 Zurich CHX), Oligonucleotide analogs containing sulfur linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Huie Edward M. (Wilmington DE) Trainor George L. (Wilmington DE), Oligonucleotide analogs with sulfamate linkages.
  • Weis Alexander Ludvik (Berwyn PA) Hausheer Frederick Herman (San Antonio TX) Chaturvedula Prasad Venkata Chala (Exton PA) Delecki Daniel Joseph (Radnor PA) Cavanaugh ; Jr. Paul Francis (West Chester , Oligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleo.
  • Chaturvedula Prasad Venkata Chala (Exton PA), Oligonucleotide dimers with amide linkages replacing phosphodiester linkages.
  • Tullis Richard H. (La Jolla CA), Oligonucleotide therapeutic agent and method of making same.
  • Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides having phosphorothioate linkages of high chiral purity.
  • Froehler Brian (Belmont CA), Oligonucleotides with inverted polarity.
  • Imbach Jean-Louis (Montpellier FRX) Gosselin Gilles J. M. (Montpellier FRX), Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon.
  • Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Shaw Barbara R. (Durham NC), Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates.
  • Cook Phillip Dan (Carlsbad CA), PNA-DNA-PNA chimeric macromolecules.
  • Nielsen Peter E. (Hjortevanget 509 DK 2980 Kokkedal DKX) Buchardt Ole (Sondergardsvej 73 DK 3500 Vaerlose DKX) Egholm Michael (Johnstrup Alle 3 DK 1923 Frederiksberg DKX) Berg Rolf H. (Strandvaenget , Peptide nucleic acids.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; legal representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having amino acid side chains.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility.
  • Petrossian Ashot (San Leandro CA) DeGiovanni Andy (Berkeley CA), Perfusion airlift bioreactor.
  • Andrezej Ptasznik ; Alberti Hayek ; Gillian M. Beattie, Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation.
  • Maddry Joseph A. (Birmingham AL) Reynolds Robert C. (Birmingham AL) Secrist John A. (Birmingham AL) Montgomery John A. (Birmingham AL) Crooks Peter A. (Lexington KY), Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO) Brill Wolfgang (Freiburg DEX) Nielsen John (Horsholm DKX), Polynucleotide phosphorodithioate.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO), Polynucleotide phosphorodithioates.
  • Mullis Kary B. (Kensington CA), Process for amplifying nucleic acid sequences.
  • Weis Alexander L. (Berwyn PA) Saha Ashis K. (Frazer PA) Hausheer Frederick H. (San Antonio TX), Process of linking nucleosides with a siloxane bridge.
  • Surani Azim M. (Cambridge GB3) Neuberger Michael S. (Cambridge GB3) Bruggemann Marianne (Cambridge GB3), Production of antibodies from transgenic animals.
  • Michnick Stephen William Watson,CAX ; Pelletier Joelle Nina,CAX ; Remy Ingrid,CAX, Protein fragment complementation assays for the detection of biological or drug interactions.
  • Michnick Stephen William Watson,CAX ; Remy Ingrid,CAX, Protein fragment complementation assays for the detection of biological or drug interactions.
  • Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Ransgenic non-human animals for producing heterologous antibodies.
  • Thomas W. Dubensky, Jr. ; John M. Polo ; Carlos E. Ibanez ; David A. Driver, Recombinant alphavirus particles.
  • Cabilly Shmuel (Monrovia CA) Heyneker Herbert L. (Burlingame CA) Holmes William E. (Pacifica CA) Riggs Arthur D. (La Verne CA) Wetzel Ronald B. (San Francisco CA), Recombinant immunoglobin preparations.
  • Nevo Zvi (Herzlia ILX) Itay Samuel (Kfar Saba ILX), Repair of cartilage and bones.
  • Klaus Michael,DEX ; Mohr Peter,CHX, Retinoids.
  • Piasio ; Roger N. ; Ryan ; James W. ; Woiszwillo ; James E., Reverse sandwich immunoassay.
  • Marigo Valeria ; Tabin Clifford J. ; Ingham Philip W.,GBX ; McMahon Andrew P., Screening assays for hedgehog agonists and antagonists.
  • Craig A. Rosen ; Steven M. Ruben ; Henrik S. Olsen ; Reinhard Ebner, Secreted protein HLHFP03.
  • Morey Kraus ; Paul T. Wilder ; Jill Friberg, Selective expansion of target cell populations.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Ladner Robert C. (Ijamsville MD) Bird Robert E. (Rockville MD) Hardman Karl (Chevy Chase MD), Single polypeptide chain binding molecules.
  • Agrawal, Sudhir; Tang, Jinyan, Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling.
  • Ledley Fred D. ; O'Malley ; Jr. Bert W., Somatic gene therapy to cells associated with fluid spaces.
  • Creemer Lawrence C. (Indianapolis IN) Kirst Herbert A. (Indianapolis IN), Stereochemical Wortmannin derivatives.
  • Wilson Elaine L. (New York NY) Gabrilove Janice (New York NY), Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors.
  • Klein Elliot S. ; Johnson Alan T. ; Standeven Andrew M. ; Beard Richard L. ; Gillett Samuel J. ; Duong Tien T. ; Nagpal Sunil ; Vuligonda Vidyasagar ; Teng Min ; Chandraratna Roshantha A., Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities.
  • Klein Elliott S. ; Johnson Alan T. ; Standeven Andrew M. ; Beard Richard L. ; Gillett Samuel J. ; Duong Tien T. ; Nagpal Sunil ; Vuligonda Vidyasagar ; Teng Min ; Chandraratna Roshantha A., Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities.
  • Klein Elliott S. ; Johnson Alan T. ; Standeven Andrew M. ; Beard Richard L. ; Gillett Samuel J. ; Duong Tien T. ; Nagpal Sunil ; Vuligonda Vidyasagar ; Teng Min ; Chandraratna Roshantha A., Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities.
  • Klein Elliott S. ; Johnson Alan T. ; Standeven Andrew M. ; Beard Richard L. ; Gillett Samuel J. ; Duong Tien T. ; Nagpal Sunil ; Vuligonda Vidyasagar ; Teng Min ; Chandraratna Roshantha A., Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities.
  • Klein Elliott S. ; Johnson Alan T. ; Standeven Andrew M. ; Beard Richard L. ; Gillett Samuel J. ; Duong Tien T. ; Nagpal Sunil ; Vuligonda Vidyasagar ; Teng Min ; Chandraratna Roshantha A., Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities.
  • Klein Elliott S. ; Johnson Alan T. ; Standeven Andrew M. ; Beard Richard L. ; Gillett Samuel J. ; Duong Tien T. ; Nagpal Sunil ; Vuligonda Vidyasagar ; Teng Min ; Chandraratna Roshantha A., Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities.
  • Gusella James F. (Framingham MA), Test for Huntington\s disease.
  • Chambon Pierre,FRX ; Gronemeyer Hinrich,DEX ; Reczek Peter R. ; Ostrowski Jacek, Therapeutic combinations of RAR antagonists and RXR agonists and use thereof.
  • Paul A. Moore ; Steven M. Ruben ; Reinhard Ebner, Tissue plasminogen activator-like protease.
  • Ledley Fred D. ; O'Malley ; Jr. Bert W., Tranformation of cells associated with fluid spaces.
  • Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals capable of producing heterologous antibodies.
  • Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals capable of producing heterologous antibodies of various isotypes.
  • Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals capable of producing heterologous antibodies of various isotypes.
  • Lonberg Nils (Redwood City CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals for producing heterologous antibodies.
  • Bollag Werner,CHX ; Klaus Michael,DEX ; Panina-Bordignon Paola,ITX ; Sinigaglia Francesco,ITX, Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists.
  • Hider Robert C. (Clacton GB2) Huehns Ernst R. (London GB2), Treatment of sickle cell disease.
  • Hwang Chan Kou ; White Steven K. ; Bennani Youssef L. ; Canan Koch Stacie S. ; Badea Beth Ann ; Hebert Jonathan J. ; Nadzan Alex M., Tricyclic retinoids, methods for their production and use.
  • Goldenberg Milton D. (11837 Gainsborough Rd. Potomac MD 20854), Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers.
  • Summerton, James E.; Weller, Dwight D., Uncharged morpholino-based polymers having achiral intersubunit linkages.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages.
  • Miles Laughton E. M. (Stanford CA), Universal reagent 2-site immunoradiometric assay using labelled anti (IgG).
  • Philip W. Ingham GB; Andrew P. McMahon ; Clifford J. Tabin, Vertebrate embryonic pattern-inducing proteins.
  • Ingham Philip W.,GB2 ; McMahon Andrew P. ; Tabin Clifford J., Vertebrate embryonic pattern-inducing proteins and uses related thereto.
  • Ingham Philip W.,GB2 ; McMahon Andrew P. ; Tabin Clifford J., Vertebrate embryonic pattern-inducing proteins, and uses related thereto.
  • Anderson, Charles Daniel; Dodd, Charlie W.; Anderson, Mark Stuart, Vessel, preferably spherical or oblate spherical for growing or culturing cells, cellular aggregates, tissues and organoids and methods for using same.
  • 문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로